Aisling Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.3M Buy
2025
Q1
$12.6M Hold
2024
Q4
$13.6M Hold
2024
Q3
$19.7M Hold
2024
Q2
$21M Hold
2024
Q1
$24.4M Hold
2023
Q4
$22.2M Hold
2023
Q3
$14.9M Hold
2023
Q2
$21.5M Hold
2023
Q1
$21.6M Hold
2022
Q4
$26.1M Hold
2022
Q3
$24.6M Hold
2022
Q2
$19.7M Hold
2022
Q1
$17.8M Hold
2021
Q4
$22.4M Hold
2021
Q3
$19.6M Hold
2021
Q2
$17.6M Hold
2021
Q1
$22.9M Hold
2020
Q4
$22.8M Hold
2020
Q3
$15.1M Hold
2020
Q2
$15.2M Buy
2020
Q1
$9.6M Buy